Skip to main content
. 2013 Jun 8;4(5):792–801. doi: 10.18632/oncotarget.1059

Figure 1. GBM Xenografts possess BTSCs.

Figure 1

Immunocytochemistry demonstrating CD133 and nestin expression in EG- (A, B) and LG-BTSCs (D,E). Phase-contrast microscopy of tumorspheres (C, F). (Scale bar = 25 μm)